Skip to main content
OpenTrials
Completed

NCT Number: NCT03533166

Effects of a 0.03% CHX Mouth Rinse in Peri-implant Mucositis

Aim: To evaluate the efficacy of a 0.03% chlorhexidine (CHX) and 0.05% cetyl pyridinium chloride (CPC) mouth rinse, as an adjunct to professionally and patient-administered mechanical plaque removal, in the treatment of peri-implant mucositis.

Material and Methods: Patients displaying peri-implant mucositis in, at least, one implant were included in this randomized, double-blinded, clinical trial. Subjects received a conventional professional prophylaxis (at baseline and 6-month visits) and were instructed to regular oral hygiene practices and to rinse, twice daily, during one year, with a 0.03% CHX and 0.05% CPC mouth rinse, or a placebo. Clinical, radiographic and microbiological data were recorded at baseline, 6 and 12 months. Disease resolution was defined as the absence of bleeding on probing (BOP). Repeated measures ANOVA, Student-t and chi square tests were used.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Peri-implant Mucositis

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Faculty of Dentistry, Univesity Complutense, Madrid

Madrid, 28040, Spain

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • the presence of, at least, one dental implant with clinical signs of peri-implant mucositis, defined as gently bleeding on probing (BOP) and/or suppuration without progressive radiographic bone loss (after at least 1 year of functional loading)

Exclusion criteria

  • untreated or recurrent periodontitis [presence of nine or more sites with PD 5 mm and with full mouth bleeding score (FMBS) > 25%];
  • implants affected by peri-implantitis, (BOP and/or suppuration and progressive radiographic bone loss);
  • removable implant-retained prosthesis;
  • history of intake of systemic antibiotics within the previous month or other chronic systemic medications that could interfere with the study outcomes;
  • and women being pregnant or breast-feeding.

Treatment and study plan

Chlorhexidine

Other

0.03% Chlorhexidine + 0.05% CPC mouth rinse

Placebo

Other

Placebo mouth rinse

Primary outcomes

  1. Change on bleeding on probing on implants

    Time frame: Change baseline-12 months

    Bleeding on probing (BOP) on implants, evaluated dichotomously (presence/absence), considering a positive score when evident bleeding was observed within 15 s after gentle probing (Jepsen et al. 2015) at baseline, 3, 6, 9 and 12 months. Primary outcome would be considered for the change between baseline and 12 months

    One blinded and calibrated investigator recorded BOP at 6 sites around implants, using a plastic periodontal probe (PCV12, HuFriedy, Chicago, IL, USA)

    Calibration was achieved in double measurement calibration sessions, with a gold standard, on six randomly selected patients within one week. The inter-examiner agreement resulting in kappa (k) values of 0.78 for BOP).

Secondary outcomes

  1. Bleeding on probing (BOP) on implants

    Time frame: Baseline

    Bleeding on probing (BOP) on implants, evaluated dichotomously (presence/absence), considering a positive score when evident bleeding was observed within 15 s after gentle probing (Jepsen et al. 2015) at baseline, 3, 6, 9 and 12 months.

    One blinded and calibrated investigator recorded BOP at 6 sites around implants, using a plastic periodontal probe (PCV12, HuFriedy, Chicago, IL, USA)

    Calibration was achieved in double measurement calibration sessions, with a gold standard, on six randomly selected patients within one week. The inter-examiner agreement resulting in kappa (k) values of 0.78 for BOP).

  2. Bleeding on probing (BOP) on implants

    Time frame: 3 months

    Bleeding on probing (BOP) on implants, evaluated dichotomously (presence/absence), considering a positive score when evident bleeding was observed within 15 s after gentle probing (Jepsen et al. 2015) at baseline, 3, 6, 9 and 12 months.

    One blinded and calibrated investigator recorded BOP at 6 sites around implants, using a plastic periodontal probe (PCV12, HuFriedy, Chicago, IL, USA)

    Calibration was achieved in double measurement calibration sessions, with a gold standard, on six randomly selected patients within one week. The inter-examiner agreement resulting in kappa (k) values of 0.78 for BOP).

  3. Bleeding on probing (BOP) on implants

    Time frame: 6 months

    Bleeding on probing (BOP) on implants, evaluated dichotomously (presence/absence), considering a positive score when evident bleeding was observed within 15 s after gentle probing (Jepsen et al. 2015) at baseline, 3, 6, 9 and 12 months.

    One blinded and calibrated investigator recorded BOP at 6 sites around implants, using a plastic periodontal probe (PCV12, HuFriedy, Chicago, IL, USA)

    Calibration was achieved in double measurement calibration sessions, with a gold standard, on six randomly selected patients within one week. The inter-examiner agreement resulting in kappa (k) values of 0.78 for BOP).

  4. Bleeding on probing (BOP) on implants

    Time frame: 9 months

    Bleeding on probing (BOP) on implants, evaluated dichotomously (presence/absence), considering a positive score when evident bleeding was observed within 15 s after gentle probing (Jepsen et al. 2015) at baseline, 3, 6, 9 and 12 months.

    One blinded and calibrated investigator recorded BOP at 6 sites around implants, using a plastic periodontal probe (PCV12, HuFriedy, Chicago, IL, USA)

    Calibration was achieved in double measurement calibration sessions, with a gold standard, on six randomly selected patients within one week. The inter-examiner agreement resulting in kappa (k) values of 0.78 for BOP).

  5. Bleeding on probing (BOP) on implants

    Time frame: 12 months

    Bleeding on probing (BOP) on implants, evaluated dichotomously (presence/absence), considering a positive score when evident bleeding was observed within 15 s after gentle probing (Jepsen et al. 2015) at baseline, 3, 6, 9 and 12 months.

    One blinded and calibrated investigator recorded BOP at 6 sites around implants, using a plastic periodontal probe (PCV12, HuFriedy, Chicago, IL, USA)

    Calibration was achieved in double measurement calibration sessions, with a gold standard, on six randomly selected patients within one week. The inter-examiner agreement resulting in kappa (k) values of 0.78 for BOP).

  6. Bleeding on probing (BOP) on teeth

    Time frame: Baseline

    Bleeding on probing (BOP) on teeth, evaluated dichotomously (presence/absence), considering a positive score when evident bleeding was observed within 15 s after gentle probing

    One blinded and calibrated investigator recorded BOP at 6 sites around all teeth, using aPCP15 periodontal probe (HuFriedy® , Chicago, IL, USA).

  7. Bleeding on probing (BOP) on teeth

    Time frame: 6 months

    Bleeding on probing (BOP) on teeth, evaluated dichotomously (presence/absence), considering a positive score when evident bleeding was observed within 15 s after gentle probing

    One blinded and calibrated investigator recorded BOP at 6 sites around all teeth, using aPCP15 periodontal probe (HuFriedy® , Chicago, IL, USA).

  8. Bleeding on probing (BOP) on teeth

    Time frame: 12 months

    Bleeding on probing (BOP) on teeth, evaluated dichotomously (presence/absence), considering a positive score when evident bleeding was observed within 15 s after gentle probing

    One blinded and calibrated investigator recorded BOP at 6 sites around all teeth, using aPCP15 periodontal probe (HuFriedy® , Chicago, IL, USA).

  9. Plaque on implants

    Time frame: Baseline

    Modified plaque index (MPlI) measured at six sites per implant (Mombelli et al. 1987):

    • Score 0: no plaque detected;
    • Score 1: plaque only recognized by running the periodontal probe across the smooth marginal surface of the implant;
    • Score 2: plaque can be seen by the naked eye;
    • Score 3: abundance of soft matter.

    One blinded and calibrated investigator recorded MPI at 6 sites around the selected implant, using a plastic periodontal probe (PCV12, HuFriedy, Chicago, IL, USA).

    Calibration was achieved in double measurement calibration sessions, with a gold standard , on six randomly selected patients within one week. The inter-examiner agreement resulting in kappa (k) values of 0.79 for MPlI.

  10. Plaque on implants

    Time frame: 6 months

    Modified plaque index (MPlI) measured at six sites per implant (Mombelli et al. 1987):

    • Score 0: no plaque detected;
    • Score 1: plaque only recognized by running the periodontal probe across the smooth marginal surface of the implant;
    • Score 2: plaque can be seen by the naked eye;
    • Score 3: abundance of soft matter.

    One blinded and calibrated investigator recorded MPI at 6 sites around the selected implant, using a plastic periodontal probe (PCV12, HuFriedy, Chicago, IL, USA).

    Calibration was achieved in double measurement calibration sessions, with a gold standard , on six randomly selected patients within one week. The inter-examiner agreement resulting in kappa (k) values of 0.79 for MPlI.

  11. Plaque on implants

    Time frame: 12 months

    Modified plaque index (MPlI) measured at six sites per implant (Mombelli et al. 1987):

    • Score 0: no plaque detected;
    • Score 1: plaque only recognized by running the periodontal probe across the smooth marginal surface of the implant;
    • Score 2: plaque can be seen by the naked eye;
    • Score 3: abundance of soft matter.

    One blinded and calibrated investigator recorded MPI at 6 sites around the selected implant, using a plastic periodontal probe (PCV12, HuFriedy, Chicago, IL, USA).

    Calibration was achieved in double measurement calibration sessions, with a gold standard , on six randomly selected patients within one week. The inter-examiner agreement resulting in kappa (k) values of 0.79 for MPlI.

  12. Plaque on teeth

    Time frame: Baseline

    Modified plaque index (MPlI) measured at six sites per tooth

    • Score 0: no plaque detected;
    • Score 1: plaque only recognized by running the periodontal probe across the smooth marginal surface of the tooth
    • Score 2: plaque can be seen by the naked eye;
    • Score 3: abundance of soft matter.

    One blinded and calibrated investigator recorded MPI at 6 sites around teeth using a PCP15 periodontal probe (HuFriedy® , Chicago, IL, USA).

  13. Plaque on teeth

    Time frame: 6 months

    Modified plaque index (MPlI) measured at six sites per tooth

    • Score 0: no plaque detected;
    • Score 1: plaque only recognized by running the periodontal probe across the smooth marginal surface of the tooth
    • Score 2: plaque can be seen by the naked eye;
    • Score 3: abundance of soft matter.

    One blinded and calibrated investigator recorded MPI at 6 sites around teeth using a PCP15 periodontal probe (HuFriedy® , Chicago, IL, USA).

  14. Plaque on teeth

    Time frame: 12 months

    Modified plaque index (MPlI) measured at six sites per tooth

    • Score 0: no plaque detected;
    • Score 1: plaque only recognized by running the periodontal probe across the smooth marginal surface of the tooth
    • Score 2: plaque can be seen by the naked eye;
    • Score 3: abundance of soft matter.

    One blinded and calibrated investigator recorded MPI at 6 sites around teeth using a PCP15 periodontal probe (HuFriedy® , Chicago, IL, USA).

  15. Probing depth on implants

    Time frame: Baseline

    Probing depth (PD) defined as the distance in mm, between the bottom of the pocket and the peri-implant mucosal margin (six sites per implant).

    One blinded and calibrated investigator recorded PD at 6 sites around implants, using a plastic periodontal probe (PCV12, HuFriedy, Chicago, IL, USA)

    Calibration was achieved in double measurement calibration sessions, with a gold standard, on six randomly selected patients within one week. The inter-examiner agreement resulted in a intraclass correlation coefficient (ICC)=0.93 for PD.

  16. Probing depth on implants

    Time frame: 6 months

    Probing depth (PD) defined as the distance in mm, between the bottom of the pocket and the peri-implant mucosal margin (six sites per implant).

    One blinded and calibrated investigator recorded PD at 6 sites around implants, using a plastic periodontal probe (PCV12, HuFriedy, Chicago, IL, USA)

    Calibration was achieved in double measurement calibration sessions, with a gold standard, on six randomly selected patients within one week. The inter-examiner agreement resulted in a intraclass correlation coefficient (ICC)=0.93 for PD.

  17. Probing depth on implants

    Time frame: 12 months

    Probing depth (PD) defined as the distance in mm, between the bottom of the pocket and the peri-implant mucosal margin (six sites per implant).

    One blinded and calibrated investigator recorded PD at 6 sites around implants, using a plastic periodontal probe (PCV12, HuFriedy, Chicago, IL, USA)

    Calibration was achieved in double measurement calibration sessions, with a gold standard, on six randomly selected patients within one week. The inter-examiner agreement resulted in a intraclass correlation coefficient (ICC)=0.93 for PD.

  18. Probing depth on teeth

    Time frame: Baseline

    Probing depth (PD) defined as the distance in mm, between the bottom of the pocket and the gingival margin (six sites per tooth).

    One blinded and calibrated investigator recorded PD at 6 sites around all teeth, using a PCP15 periodontal probe (HuFriedy® , Chicago, IL, USA).

  19. Probing depth on teeth

    Time frame: 6 months

    Probing depth (PD) defined as the distance in mm, between the bottom of the pocket and the gingival margin (six sites per tooth).

    One blinded and calibrated investigator recorded PD at 6 sites around all teeth, using a PCP15 periodontal probe (HuFriedy® , Chicago, IL, USA).

  20. Probing depth on teeth

    Time frame: 12 months

    Probing depth (PD) defined as the distance in mm, between the bottom of the pocket and the gingival margin (six sites per tooth).

    One blinded and calibrated investigator recorded PD at 6 sites around all teeth, using a PCP15 periodontal probe (HuFriedy® , Chicago, IL, USA).

  21. Crown-length implant

    Time frame: Baseline

    Crown-length implant (CLI), defined as the distance in mm, between the incisal/occlusal portion of the crown and the peri-implant mucosal margin at the mid-buccal site.

    One blinded and calibrated investigator recorded CLI around the selected implant, using a plastic periodontal probe (PCV12, HuFriedy, Chicago, IL, USA).

    Calibration was achieved in double measurement calibration sessions, with a gold standard , on six randomly selected patients within one week. The inter-examiner agreement resulted in a intraclass correlation coefficient of 0.96 for CLI.

  22. Crown-length implant

    Time frame: 6 months

    Crown-length implant (CLI), defined as the distance in mm, between the incisal/occlusal portion of the crown and the peri-implant mucosal margin at the mid-buccal site.

    One blinded and calibrated investigator recorded CLI around the selected implant, using a plastic periodontal probe (PCV12, HuFriedy, Chicago, IL, USA).

    Calibration was achieved in double measurement calibration sessions, with a gold standard , on six randomly selected patients within one week. The inter-examiner agreement resulted in a intraclass correlation coefficient of 0.96 for CLI.

  23. Crown-length implant

    Time frame: 12 months

    Crown-length implant (CLI), defined as the distance in mm, between the incisal/occlusal portion of the crown and the peri-implant mucosal margin at the mid-buccal site.

    One blinded and calibrated investigator recorded CLI around the selected implant, using a plastic periodontal probe (PCV12, HuFriedy, Chicago, IL, USA).

    Calibration was achieved in double measurement calibration sessions, with a gold standard , on six randomly selected patients within one week. The inter-examiner agreement resulted in a intraclass correlation coefficient of 0.96 for CLI.

  24. Recession on teeth

    Time frame: Baseline

    Recession (REC), defined as the distance in mm, between the gingival margin and the cements-enamel junction.

    One blinded and calibrated investigator recorded REC around all teeth using a PCP15 periodontal probe (HuFriedy® , Chicago, IL, USA).

  25. Recession on teeth

    Time frame: 6 months

    Recession (REC), defined as the distance in mm, between the gingival margin and the cements-enamel junction.

    One blinded and calibrated investigator recorded REC around all teeth using a PCP15 periodontal probe (HuFriedy® , Chicago, IL, USA).

  26. Recession on teeth

    Time frame: 12 months

    Recession (REC), defined as the distance in mm, between the gingival margin and the cements-enamel junction.

    One blinded and calibrated investigator recorded REC around all teeth using a PCP15 periodontal probe (HuFriedy® , Chicago, IL, USA).

  27. Microbiological outcomes_total counts

    Time frame: Baseline

    Pooled subgingival samples were obtained from the two most inflamed accessible sites of the selected implant in each patient.

    Samples were taken with two consecutive sterile medium paper-points (#30, Maillefer, Ballaigues, Switzerland) that were kept in place for 10 s and then transferred into a screw-capped vial containing 1.5 ml of reduced transport fluid (RTF) (Syed & Loesche 1972). Samples were transported to the microbiology laboratory within 2 h, where aliquots of 0.1 mL were plated in different culture media.

    Counts were transformed in colony-forming units (CFU) per mL of the original sample. Total anaerobic counts and counts of selected periodontal pathogens (A. actinomycetemcomitans, Tannerella forsythia, Porphyromonas gingivalis, Prevotella intermedia/nigrescens, Parvimonas micra, Eikenella corrodens, Campylobacter rectus and Fusobacterium nucleatum) were calculated.

  28. Microbiological outcomes_total counts

    Time frame: 6 months

    Pooled subgingival samples were obtained from the two most inflamed accessible sites of the selected implant in each patient.

    Samples were taken with two consecutive sterile medium paper-points (#30, Maillefer, Ballaigues, Switzerland) that were kept in place for 10 s and then transferred into a screw-capped vial containing 1.5 ml of reduced transport fluid (RTF) (Syed & Loesche 1972). Samples were transported to the microbiology laboratory within 2 h, where aliquots of 0.1 mL were plated in different culture media.

    Counts were transformed in colony-forming units (CFU) per mL of the original sample. Total anaerobic counts and counts of selected periodontal pathogens (A. actinomycetemcomitans, Tannerella forsythia, Porphyromonas gingivalis, Prevotella intermedia/nigrescens, Parvimonas micra, Eikenella corrodens, Campylobacter rectus and Fusobacterium nucleatum) were calculated.

  29. Microbiological outcomes_total counts

    Time frame: 12 months

    Pooled subgingival samples were obtained from the two most inflamed accessible sites of the selected implant in each patient.

    Samples were taken with two consecutive sterile medium paper-points (#30, Maillefer, Ballaigues, Switzerland) that were kept in place for 10 s and then transferred into a screw-capped vial containing 1.5 ml of reduced transport fluid (RTF) (Syed & Loesche 1972). Samples were transported to the microbiology laboratory within 2 h, where aliquots of 0.1 mL were plated in different culture media.

    Counts were transformed in colony-forming units (CFU) per mL of the original sample. Total anaerobic counts and counts of selected periodontal pathogens (A. actinomycetemcomitans, Tannerella forsythia, Porphyromonas gingivalis, Prevotella intermedia/nigrescens, Parvimonas micra, Eikenella corrodens, Campylobacter rectus and Fusobacterium nucleatum) were calculated.

  30. Microbiological outcomes_frequency of detection

    Time frame: Baseline

    The frequency of detection was calculated as presence/absence of each periodontal pathogen

  31. Microbiological outcomes_frequency of detection

    Time frame: 6 months

    The frequency of detection was calculated as presence/absence of each periodontal pathogen

  32. Microbiological outcomes_frequency of detection

    Time frame: 12 months

    The frequency of detection was calculated as presence/absence of each periodontal pathogen

  33. Microbiological outcomes_proportions

    Time frame: Baseline

    The proportions for each bacterial species was calculated by dividing the counts of each pathogen by the total counts.

  34. Microbiological outcomes_proportions

    Time frame: 6 months

    The proportions for each bacterial species was calculated by dividing the counts of each pathogen by the total counts.

  35. Microbiological outcomes_proportions

    Time frame: 12 months

    The proportions for each bacterial species was calculated by dividing the counts of each pathogen by the total counts.

  36. Radiographic bone loss on implants

    Time frame: Baseline

    Standardized periapical radiographs using the parallel technique (Rinn® system, Dentsply, Weybridge, United Kingdom) were used to evaluate changes in the radiographic marginal bone levels (MBL).

    Scanned images were measured both at the mesial and distal sites using as landmarks the implant shoulder and the first bone implant contact (BIC) of the selected implant using an image analysis software (J-image).

    After a session of calibration (ICC=0.99), two investigators performed all the radiographic measurements.

  37. Radiographic bone loss on implants

    Time frame: 3 months

    Standardized periapical radiographs using the parallel technique (Rinn® system, Dentsply, Weybridge, United Kingdom) were used to evaluate changes in the radiographic marginal bone levels (MBL).

    Scanned images were measured both at the mesial and distal sites using as landmarks the implant shoulder and the first bone implant contact (BIC) of the selected implant using an image analysis software (J-image).

    After a session of calibration (ICC=0.99), two investigators performed all the radiographic measurements.

  38. Radiographic bone loss on implants

    Time frame: 12 months

    Standardized periapical radiographs using the parallel technique (Rinn® system, Dentsply, Weybridge, United Kingdom) were used to evaluate changes in the radiographic marginal bone levels (MBL).

    Scanned images were measured both at the mesial and distal sites using as landmarks the implant shoulder and the first bone implant contact (BIC) of the selected implant using an image analysis software (J-image).

    After a session of calibration (ICC=0.99), two investigators performed all the radiographic measurements.

  39. Staining

    Time frame: Baseline

    Staining of teeth will be scored using the Gründemann modification of the stain index (GMSI) (Grundemann et al. 2000), recorded at nine areas per tooth (three mesial, three medial, three distal). Stain will be graded using the intensity stain index of Lobene (1968).

  40. Staining

    Time frame: 6 months

    Staining of teeth will be scored using the Gründemann modification of the stain index (GMSI) (Grundemann et al. 2000), recorded at nine areas per tooth (three mesial, three medial, three distal). Stain will be graded using the intensity stain index of Lobene (1968).

  41. Staining

    Time frame: 12 months

    Staining of teeth will be scored using the Gründemann modification of the stain index (GMSI) (Grundemann et al. 2000), recorded at nine areas per tooth (three mesial, three medial, three distal). Stain will be graded using the intensity stain index of Lobene (1968).

  42. Adverse effect

    Time frame: Baseline

    A questionnaire will be filled to assess the patient-based variables and side effects, by the patients. They will be evaluated with a visual analogue scale (0-10)

  43. Adverse effect

    Time frame: 6 months

    A questionnaire will be filled to assess the patient-based variables and side effects, by the patients. They will be evaluated with a visual analogue scale (0-10)

  44. Adverse effect

    Time frame: 12 months

    A questionnaire will be filled to assess the patient-based variables and side effects, by the patients. They will be evaluated with a visual analogue scale (0-10)

Sponsors and collaborators

Lead sponsor

Universidad Complutense de Madrid

Other

Collaborators

  • Dentaid SL

Registry information

Official study title

Clinical and Microbiological Effects of a 0.03% Chlorhexidine Mouth Rinse in the Prevention of Peri-implant Diseases: a Randomized Clinical Trial

Important dates

Study start
2015
Primary completion
2017
Study completion
2017
First posted
May 23, 2018
Registry last updated
May 23, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.